May 15, 2019 / 10:00PM GMT
Tazeen Ahmad - BofA Merrill Lynch, Research Division - VP
(technical difficulty)
biotech analyst here at Bank of America Merrill Lynch, thanks for attending our health care conference.
Our next presenting company is Alector. Speaking for Alector today is CEO, Arnon Rosenthal. He will be going through a list of slides. And then once that's done, we can switch over to Q&A. So if any of you have questions from the audience, please feel free to let us know. Thanks.
Arnon Rosenthal - Alector, Inc. - Co-Founder, CEO, President & Director
Thank you. I'm Arnon, the CEO and Co-founder of Alector. At Alector, we -- our mission is to cure degenerative brain disorder, and we developed a completely novel approach to do that. Instead of dealing with the pathologies directly, dealing with beta amyloid or TAU, we are recruiting the immune system to cure the disease for us. And in this respect, we are very similar to immuno-oncology where instead of trying to kill the tumor directly, you recruit the immune system to do the work for you. And with this
Alector Inc at Bank of America Merrill Lynch Health Care Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers